Topic guide
UK Law & Regulation
A plain-English route through controlled-drug scheduling, research access, treatment claims and provider regulation in the UK.
Start with context
Legal classification, medicine approval, professional registration and healthcare-provider regulation are separate systems. A research trial or overseas service does not automatically create lawful, approved treatment access in the UK.
Questions this topic raises
- What substance, jurisdiction and activity are involved?
- Is the claim about research, prescribing or commercial access?
- Which regulator—if any—oversees the service?
- Are professional credentials independently verifiable?
- Could the advertising imply approval that does not exist?
Read the evidence guides
Psychedelic Medicine and UK Law: Research, Scheduling and Access
UK drug classes, schedules, research licences and the difference between trials and routine access.
How to Spot Misleading Psychedelic Clinic and Retreat Claims
Test treatment promises, credentials, regulation, testimonials and safety claims before money or trust changes hands.
Ketamine and Classic Psychedelics Are Not the Same
Compare pharmacology, clinical use, evidence, legal status and risk.
MDMA-Assisted Therapy for PTSD: Evidence, Limits and Approval Status
What phase 3 trials reported, why the FDA did not approve the application and what remains unresolved.
Screening, Contraindications and Risk in Psychedelic Research
What clinical trials screen and monitor—and why selected study populations cannot be generalised.
Keep the boundary clear
These guides are educational. They do not provide medical advice, personalised risk assessment, legal advice or instructions for using a controlled substance.
